Skip to content
Screener

Amylyx Pharmaceuticals, Inc. AMLX Prepaid & Other Current

Prepaid & Other Current at other companies

MBX Biosciences, Inc. logo
MBX Biosciences, Inc.MBX
$8.56M+145%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$1.22M+41.5%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$22.36M+36.1%
VAN
Vivani MedicalVANI
$1.1M-33.9%
uniQure logo
uniQureQURE
$10.25M-44.7%
AdaptHealth logo
AdaptHealthAHCO
$88.28M+109%

Other financials

Income statement

See full
Revenue-
Gross profit-
Operating income-$45.7M-6.6%
Net income-$43.4M-4.8%
EPS (diluted)-$0.39+15.2%

Balance sheet

See full
Cash & equivalents$49.3M-15.1%
Total debt$5.3M-11.9%
Total equity$239.2M+42.5%
Total assets$264.6M+36.0%

Cash flow

See full
Operating cash flow-$31.4M-24.5%
CapEx$86.0K+330%
Free cash flow-$28.0M+52.6%

Valuation

See full
Market cap$2.54B+265%
Enterprise value$2.5B+287%

Profitability

See full
Gross margin100%+6.9pp
Operating margin-47,349.8%-47,409pp
Net margin-45,096.2%-45,152pp
FCF margin-39,826.7%-39,847pp

Returns & leverage

See full
Return on equity-74.7%-9.5pp
Debt / equity0.0×
Current ratio12.1×+3.4×

Where this comes from

Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The source filing: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 7:04 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336682

FAQ

What is Amylyx Pharmaceuticals, Inc.'s prepaid & other current?
Amylyx Pharmaceuticals, Inc. (AMLX) reported prepaid & other current of $5.58M in Q2 2026.
How has Amylyx Pharmaceuticals, Inc.'s prepaid & other current changed year-over-year?
Amylyx Pharmaceuticals, Inc.'s prepaid & other current decreased by 6.4% year-over-year, from $5.96M to $5.58M.
What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s prepaid & other current?
Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s prepaid & other current has grown at a 47.3% compound annual growth rate (CAGR), from $7.16M to $33.69M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about Amylyx Pharmaceuticals, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude